“SGLT2 Inhibitor Safety Signals in FAERS Ketoacidosis and Other Adverse Events across 154,476 Spontaneous Reports”. Diabzen, vol. 4, no. 16, July 2026, pp. 32-33, https://thediabzen.com/index.php/d/article/view/59.